Connect with us


Government extended international flight suspension till December 31.



Government has extended international flight suspension further till December 31, in a new order issued by Govt, the international flight ban has been extended by the Directorate General of Civil Aviation (DGCA) amid the ongoing coronavirus pandemic. “However, selected flights shall be allowed on case to case basis”: DGCA.

International flights to and from India have been suspended till December 31 this 12 months in view of the coronavirus pandemic and planes will fly only on select routes on a case-to-case foundation, the Directorate Normal of Civil Aviation (DGCA) mentioned in a round on Thursday. The restrictions, nonetheless, should not relevant to international all-cargo operations and flights specifically accredited by the DGCA, it added. The prolonged suspension comes at a time when the nation’s Covid-19 tally has soared previous 9.26 million whereas 135,223 folks have died of the illness.

“In partial modification of round dated 26-06-2020, the competent authority has additional prolonged the validity of round issued on the topic cited above concerning Scheduled International business passenger providers to/from India till 2359 hr 1ST of 31St December, 2020,” DGCA mentioned in a notification ‘Journey and Visa restrictions associated to Covid-19’.

The aviation regulator had earlier prolonged the suspension of international flight operations till November 30 and similarity allowed planes to fly on select routes. Nonetheless, particular international flights have been working underneath the Vande Bharat Mission since Might and underneath the bilateral ‘air bubble’ preparations with chosen international locations since July.

India has fashioned air bubble pacts with round 18 international locations, together with the US, the UK, the UAE, Kenya, Bhutan and France. Underneath an air bubble pact between two international locations, particular international flights could be operated by their airways between their territories.

Scheduled home passenger flights resumed in India on Might 25 after a spot of two months amid the pandemic state of affairs.


447 cases of adverse effect reported,Covid-19 vaccine given to 2,24,301 beneficiaries :Govt.



A total of 2,24,301 beneficiaries have been inoculated with COVID-19 vaccine so far, out of which only 447 adverse events following immunisation (AEFI) were reported, the Union Health Ministry said on day two of the nationwide vaccination drive on Sunday.

Addressing a press briefing, the ministry’s Additional Secretary Manohar Agnani said out of the 447 adverse events following immunisation, only three required hospitalisation.

“Today being Sunday, only six states conducted vaccination drive and in 553 sessions a total of 17,072 beneficiaries were vaccinated,” he said.

The six states where the vaccination drive was carried out on Sunday are Andhra Pradesh, Arunachal Pradesh, Karnataka, Kerala, Manipur and Tamil Nadu, he added.

Agnani said a total of 2,24,301 beneficiaries have been vaccinated till January 17 as per provisional reports, adding that 2,07,229 of them received the jabs on day one of the drive.

“A total of 447 AEFI have been reported on January 16 and 17, out of which only three required hospitalisation. Most of the AEFI reported so far are minor like fever, headache, nausea,” he said.

He said a meeting was held with all states and union territories on Sunday to review the progress of the drive, identify bottlenecks and plan corrective actions.

Prime Minister Narendra Modi rolled out the world’s largest inoculation drive against COVID-19 on Saturday and said the two vaccines being deployed will ensure a “decisive victory” for India against the pandemic.

India has approved two vaccines—Covaxin developed by Bharat Biotech and Covishield from the Oxford/AstraZeneca stable being manufactured by the Serum Institute of India—for emergency use in the country.

According to the government, the shots will be offered first to an estimated one crore healthcare workers and around two coror frontline workers, and then to persons above 50 years of age, followed by persons younger than 50 years of age with associated comorbidities. PTI

Continue Reading